KTOV got a USA partnership for their new FDA approved drug Consensi but no buyout. Stock was up 44% but warrants were down 17%. Would be better to just buy stock since warrants expire November 25 2020. They are developing a new cancer drug also in the future so some risk for sure long term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.